China Journal of Leprosy and Skin Diseases ›› 2018, Vol. 34 ›› Issue (1): 53-56.

Previous Articles     Next Articles

Therapeutic update of Henoch-Schonlein Purpura

WANG Jinzhao,SHI Nian,MAO Hui.   

  1. Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi 435000,China
  • Online:2018-01-15 Published:2018-12-05
  • Contact: SHI nian, E-mail:635653672@qq.com

Abstract: The bases for the treatment of Henoch-Schonlein Purpura (HSP)mainly are symptomatic, such as anti-anaphylaxis, vitamin and calcium supplement. However, the therapies for those who have involvement of severe arthritis, gastrointestinal?complications and nephritis should be personalized, including corticosteroid, immunosuppressant, decoagulants, plasmapheresis, traditional Chinese mdicine and so on, which is reviewed in this article.